VERSATILE SYSTEM
LiDia-SEQ™ combines powerful analytical capability and accurate results with speed and simplicity of use.
Diagnostic tests are in development for multiple healthcare applications where rapid point-of-need diagnostics are of critical need:
- Bloodstream infection pathogen identification
- Antimicrobial resistance
- Viral and pandemic
- Liquid biopsy for diagnostics and monitoring

SIMPLE
Easy to operate
providing 24/7
diagnostics

FAST
Results in a few hours
at the point of need

ACCURATE
Highly sensitive and
specific
Sepsis
As drug resistant bacteria become more common, so will deaths from life-threatening infections like sepsis, which is the body’s unregulated immune response to a severe bloodstream infection. Sepsis is a medical emergency that requires rapid diagnosis and treatment. Sepsis can lead to multiple organ failure and even death if not recognised and treated promptly.
Despite the best antibiotics and intensive care, sepsis is the primary cause of death from infection. Every three seconds, someone in the world dies of sepsis; globally sepsis claims 11 million lives a year4. Sepsis cases are increasing, up by between 8% and 13% over the last decade, claiming more lives than bowel and breast cancer combined.
- Every 3 seconds someone dies of sepsis
- 5,600 people diagnosed with sepsis every hour
- 1,255 people die every hour
- 49M people diagnosed every year
- 11M sepsis-related deaths every year

2 Million
Sepsis cases a year
in the US alone

30-50%
fatality rate

$38.2 BILLION
in treatment
costs a year
The $ value is US only, global figure not readily available.